Navigation Links
Computerized Scan Detects Heart Disease
Date:4/28/2009

And prevents unnecessary testing, hospitalization, study shows

TUESDAY, April 28 (HealthDay News) -- A computerized chest scan successfully singles out those people coming into emergency rooms with chest pains who have serious heart disease, a new study indicates.

Of the 368 people in the study, computed tomography angiography (CTA) was 100 percent effective in identifying the 31 who actually had acute coronary syndrome, according to a report in the April 28 issue of the Journal of the American College of Cardiology. None of the people who were cleared by the scans had a coronary event in the following six months.

"The study really shows that in this population, CTA is useful and would be good to tremendously improve triage of these patients," said study author Dr. Udo Hoffman, an associate professor of radiology at Harvard Medical School and Massachusetts General Hospital.

Triage -- identifying who needs immediate care and who doesn't -- is of increasing importance as hospitals try to cut medical costs. Many people who come to emergency rooms with chest pains now undergo a series of tests, often being hospitalized. Even though CTA is expensive, at about $1,500 a test, it could save money by eliminating unnecessary hospitalization.

The people in the study were at relatively high risk of coronary disease. Yet the CTA scan, which gives a 64-slice image of the heart, found that most of them did not require immediate hospitalization and further testing.

The case for using CTA for triage in suspected heart disease is not completed, Hoffman said. "The next step is a randomized trial," he said. "We have to look at physician behavior, how physicians will adopt this technology."

But, he added, "I think in places where there is a lot of expertise, there may be enough evidence to use it."

That certainly is true at the University of Pennsylvania, said Dr. Judd Hollander, clinica
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Computerized Jump Rope Raises Funds for Breast Cancer Research
2. Computerized training of working memory is a promising therapeutic strategy in ADHD
3. New Computerized Scans Effective for Spotting Clogged Arteries
4. Rosalind Franklin University of Medicine and Science First in Illinois to Equip Students With Computerized Diagnosis System
5. Computerized writing aids make writing easier for persons with aphasia
6. Computerized mobile health support systems
7. Computerized Brain Exercise Improves Memory
8. New technique detects specific chromosomal damage, may indicate lung cancer risk
9. Blood protein detects lung cancer, even at earliest stage
10. CT colonography detects wide-range of extracolonic abnormalities in elderly patients
11. McMaster test detects the most prevalent respiratory viruses
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Computerized Scan Detects Heart Disease
Computerized Scan Detects Heart Disease
Breaking Medicine Technology:DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 1Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 4Natural born divers and the molecular traces of evolution 9035 1Natural born divers and the molecular traces of evolution 9035 2Reading the brain without poking it 9033 1Reading the brain without poking it 9033 2Reading the brain without poking it 9033 3Reading the brain without poking it 9033 4Reading the brain without poking it 9033 5